Compare AVO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | NEO |
|---|---|---|
| Founded | 1983 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Precision Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2020 | 2008 |
| Metric | AVO | NEO |
|---|---|---|
| Price | $12.36 | $8.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $17.00 | $13.38 |
| AVG Volume (30 Days) | 930.8K | ★ 2.1M |
| Earning Date | 06-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.92 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,391,200,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $3.06 | $9.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.68 | N/A |
| 52 Week Low | $10.00 | $4.72 |
| 52 Week High | $15.53 | $13.74 |
| Indicator | AVO | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 54.27 |
| Support Level | $11.55 | $8.68 |
| Resistance Level | $13.01 | $8.84 |
| Average True Range (ATR) | 0.45 | 0.43 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 22.60 | 41.77 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.